Crossmark

Circulating small extracellular vesicle-encapsulated SEMA5A-IT1 attenuates myocardial ischemia–reperfusion injury after cardiac surgery with cardiopulmonary bypass

Crossref DOI link: https://doi.org/10.1186/s11658-022-00395-9

Published Online: 2022-10-25

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Ting

Shi, Guoning

Ji, Zhenhua

Wang, Shu

Geng, Lizhu

Guo, Zhigang https://orcid.org/0000-0002-2978-7703
Funding

Funding for this research was provided by:

the Natural Science Foundation of Tianjin (21JCYBJC00560)
License Information

Text and Data Mining valid from 2022-10-25

Version of Record valid from 2022-10-25
More Information

Article History

Received: 10 June 2022

Accepted: 10 October 2022

First Online: 25 October 2022

Declarations

:

: All procedures involving human material have been performed in accordance with the Declaration of Helsinki and approved by the institutional review board of Tianjin Chest Hospital (no. 2020YS-010-01).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below